GlobalData on MSN

RevBio receives FDA clearance for cranial bone glue trial

The FDA has authorised up to 15 clinical sites to take part in the study.

FDA Greenlights RevBio’s Pivotal Clinical Trial for its Cranial Flap Bone Glue

RevBio, Inc., announced that it has received investigational device exemption (IDE) approval from the FDA to conduct a ...
Business Wire

RevBio Receives a $2.4 Million NIH Grant to Conduct a First-in-Human Clinical Trial for its Regenerative Bone Adhesive for Cranial Flap Fixation and Enrolls First Five Patients

This Clinical Trial will Show Preliminary Safety and Probable Benefit of TETRANITE ® for Replacing the Use of Metal Plates and Screws LOWELL, Mass.--(BUSINESS WIRE)--RevBio, Inc., announced that it ...